Zannan Pharma is a contract synthesis and process development company based in Shanghai, China. Dr. Zhan has served as President and CTO since Zannan founded. Zhan received his Ph.D. with Prof. David Lynn from the University of Chicago and served as a post-doctoral fellow in Med. Chem. with Prof. Peter Dervan at California Institute of Technology and as a research associate with Nobel Laureate Barry Sharpless at the Scripps Research Institute. Prior to joining Zannan, Zhan had worked at Schering-Plough and Array Biopharma in drug discovery and process development for 6 years.

Zannan has state-of-the-art facilities and experienced chemists to work on diversity of R&D projects efficiently. Currently, Zannan provides: (1) “Zhan (Ru) Catalysts” highly efficient for metathesis; (2) high-quality building blocks and catalog products; (3) custom synthesis and FTE contract research from lab-scale to pilot; (4) process R&D and manufacturing in China, which would facilitate the drug discovery and process development for our customers, who could save their efforts and cost. Moreover, Zannan Chemists also focus on development of the synthetic routes and methodologies (e.g., Zhan Catalysts for metathesis) for customer R&D projects.